Severe thalassaemia intermedia with multiple fractures: Role of transfusion therapy

Journal of the Pakistan Medical Association

Volumn 61, Issue 11, 2011, Pages 1137-1139

  Ahmad, Saqib Qayyum ^a   Iqbal, Mudassar ^a   Wahla, Madiha Saeed ^a   Tarrar, Aimel Munir ^a  

^a PAF Hospital   (Pakistan)

Author keywords

Fractures; Thalassaemia int ermedia; Transfusion chelation

Indexed keywords

ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; ASCORBIC ACID; CALCIUM; FOLIC ACID; HEMOGLOBIN; VITAMIN D;

ANKLE; ARTICLE; BLOOD ANALYSIS; BLOOD SMEAR; BLOOD TRANSFUSION; BONE FRAGILITY; BONE RADIOGRAPHY; CASE REPORT; CHILD; DISEASE SEVERITY; FEMALE; FEVER; FRACTURE HEALING; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOSITY; HUMAN; MUTATIONAL ANALYSIS; PAIN; PHYSICAL EXAMINATION; SCHOOL CHILD; SPLINTING; THALASSEMIA; THALASSEMIA INTERMEDIA; WRIST;

ANTI-BACTERIAL AGENTS; ANTIPYRETICS; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; FEMALE; FRACTURES, BONE; HUMANS; IRON CHELATING AGENTS; SEVERITY OF ILLNESS INDEX; THALASSEMIA; TREATMENT OUTCOME; VITAMINS;

EID: 80054875792     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Tahir A, Ismaeel H, Cappellini M D. Thalassaemia intermedia: Revisited. Blood Cells Mol Dis 2006; 37: 12-20.
2. Mohamed N, Jackson N. Severe thalassaemia intermedia: clinical problems in the absence of hypertransfusion. Blood Rev 1998; 12: 163-170.
3. Phadke SR, Agarwal S. Phenotype score to grade the severity of thalassemia intermediate. Indian J Pediatr 2003; 70: 477-481.
4. Borgna-Pignatti C, Marsella M, Zanforlin N. The natural history of thalassaemia intermedia. Ann N Y Acad Sci 2010; 1202: 214-220.
5. Thein S L. Genetic insights into the clinical diversity of? thalassaemia. Br J Haematol 2004; 124: 264-274.
6. Ahmed S, Petrou M, Saleem M. Molecular genetics of -thalassaemia in Pakistan: a basis for prenatal diagnosis. Br J Haematol 1996; 94: 476-481.
7. Aessopos A, Kati M, Meletis J. Thalassaemia intermedia today: should patients regularly receive transfusions? Transfusion 2007; 47: 792-800.
8. Cappellini M D, Musallam K M, Taher A T. Insight onto the Pathophysiology and Clinical Complications of Thalassaemia Intermedia. Hemoglobin 2009; 33: 145-159.
9. Borgna-Pignatti C. Modern treatment of thalassaemia intermedia. Br J Haematol 2007; 38: 291-304.
10. Taher A T, Musallam KM, Cappellini M D, Weatherall D J. Optimal management of? thalassaemia intermedia. Br J Haematol 2011; 152: 512-523.